Non-alcoholic fatty liver disease (NAFLD) is a terrible disease affecting many around the globe. The condition has a staggering prevalence of 30% worldwide. And that’s not all! Nearly 2 million people lose their battle against NAFLD each year globally. NAFLD is marked by the accumulation of fat and inflammation in the liver. The disease is …
More
New Research Manages to Control Liver Inflammation by Merging Nicotinamide Riboside Supplement with a Sirtuins Activator
Nicotinamide Riboside Cancer Treatment: NR Holds the Key to Reversing Radiation-Induced Premature Ageing
Cancer treatments have long been a beacon of hope. Yet the resulting accelerated ageing has remained a challenge, especially for childhood cancer survivors. Radiotherapy using ionising radiation, a vital weapon in the fight against cancerous tumours, contributes to premature ageing. It brings with it chronic health issues for a significant percentage of survivors. What’s alarming …
More
